Syncona Limited Issue of shares pursuant to LTIP and PDMR dealings (2484F)
July 11 2019 - 6:21AM
UK Regulatory
TIDMSYNC
RNS Number : 2484F
Syncona Limited
11 July 2019
Syncona Limited
Issue of shares pursuant to Long Term Incentive Plan and PDMR
dealings
11 July 2019
Syncona Limited (the "Company") today announces that a total of
1,583,138 new ordinary shares will be issued in satisfaction of
realisations under the Company's Long Term Incentive Plan. The new
ordinary shares, when issued, will rank pari passu with the
existing issued ordinary shares of the Company. In accordance with
the rules of the Long Term Incentive Plan, the number of ordinary
shares to be issued has been calculated using the closing
mid-market price on 10 July 2019, GBP2.17.
In accordance with the rules of the Long Term Incentive Plan,
ordinary shares delivered on realisation may not be sold or
transferred by the recipient for a period of one year following the
realisation date.
The issue of shares include the following shares to be issued to
senior members of the Syncona Investment Management Limited (SIML)
leadership team:
Name SIML Title No. of shares to be
issued
Martin Murphy Chief Executive Officer 508,879
-------------------------- --------------------
Chris Hollowood Chief Investment Officer 286,996
-------------------------- --------------------
John Bradshaw Chief Financial Officer 101,143
-------------------------- --------------------
Application has been made to the Financial Conduct Authority for
the shares to be admitted to the Official List, and to the London
Stock Exchange for the shares to be admitted to trading and it is
expected that dealings will commence in the new ordinary shares on
17 July 2019.
Notification of transactions by Persons Discharging Managerial
Responsibilities ("PDMRs") are set out below.
[ENDS]
Enquiries
Syncona Ltd
Siobhan Weaver / Annabel Clay
Tel : +44 (0) 20 3981 7940
FTI Consulting
Brett Pollard / Natalie Garland-Collins
Tel: +44 (0) 20 3727 1000
Copies of this press release and other corporate information can
be found on the company website at: www.synconaltd.com
About Syncona
Syncona is a leading FTSE250 healthcare company focused on
founding, building and funding global leaders in life science. Our
vision is to deliver transformational treatments to patients in
truly innovative areas of healthcare while generating superior
returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital,
and are established leaders in gene and cell therapy. We focus on
delivering dramatic efficacy for patients in areas of high unmet
need.
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Martin Murphy
--------------------- ----------------------------------------
b) Position / Chief Executive Officer, SIML
status
--------------------- ----------------------------------------
c) Initial notification Initial Notification
/ amendment
--------------------- ----------------------------------------
2. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------
a) Description Ordinary shares
of the financial GG00B8P59C08
instrument
--------------------- ----------------------------------------
b) Nature of Issue of shares pursuant to the Syncona
the transaction Long Term Incentive Plan
--------------------- ----------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) 2.17 508,879
--------------------- ----------------------------------------
d) Aggregated
information
Aggregated N/A
volume
Price
--------------------- ----------------------------------------
e) Date of the 11 July 2019
transaction
--------------------- ----------------------------------------
f) Place of the Outside a trading venue
transaction
--------------------- ----------------------------------------
g) Currency GBP - British Pound
--------------------- ----------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name Chris Hollowood
--------------------- ----------------------------------------
b) Position / Chief Investment Officer, SIML
status
--------------------- ----------------------------------------
c) Initial notification Initial Notification
/ amendment
--------------------- ----------------------------------------
2. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------
a) Description Ordinary shares
of the financial GG00B8P59C08
instrument
--------------------- ----------------------------------------
b) Nature of Issue of shares pursuant to the Syncona
the transaction Long Term Incentive Plan
--------------------- ----------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) 2.17 286,996
--------------------- ----------------------------------------
d) Aggregated
information
Aggregated N/A
volume
Price
--------------------- ----------------------------------------
e) Date of the 11 July 2019
transaction
--------------------- ----------------------------------------
f) Place of the Outside a trading venue
transaction
--------------------- ----------------------------------------
g) Currency GBP - British Pound
--------------------- ----------------------------------------
1. Details of PDMR / person closely associated with them
("PCA")
a) Name John Bradshaw
--------------------- ----------------------------------------
b) Position / Chief Financial Officer, SIML
status
--------------------- ----------------------------------------
c) Initial notification Initial Notification
/ amendment
--------------------- ----------------------------------------
2. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------
a) Description Ordinary shares
of the financial GG00B8P59C08
instrument
--------------------- ----------------------------------------
b) Nature of Issue of shares pursuant to the Syncona
the transaction Long Term Incentive Plan
--------------------- ----------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) 2.17 101,143
--------------------- ----------------------------------------
d) Aggregated
information
Aggregated N/A
volume
Price
--------------------- ----------------------------------------
e) Date of the 11 July 2019
transaction
--------------------- ----------------------------------------
f) Place of the Outside a trading venue
transaction
--------------------- ----------------------------------------
g) Currency GBP - British Pound
--------------------- ----------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOEBFLFFKDFFBBD
(END) Dow Jones Newswires
July 11, 2019 06:21 ET (10:21 GMT)
Syncona (LSE:SYNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2023 to Apr 2024
